Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 2/20 | 0.70 |
| ▸ | LCK | P06239 | 1/20 | 0.60 |
| ▸ | PPARD | Q03181 | 1/20 | 0.60 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.60 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.60 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6754117 | 0.92 | ZDHHC7 (0.70) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL18831841 | 0.92 | ZDHHC7 (0.70) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL8056261 | 0.92 | ZDHHC7 (0.70) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL27043090 | 0.92 | ZDHHC7 (0.70) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL8063027 | 0.92 | ZDHHC7 (0.70) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL10709722 | 0.92 | ZDHHC7 (0.58) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL31206776 | 0.89 | ZDHHC7 (0.65) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL1415492 | 0.88 | ZDHHC7 (0.63) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL4704070 | 0.86 | ZDHHC7 (0.72) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL5708286 | 0.86 | ZDHHC7 (0.72) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112028741-B | Electrolyte for ultrahigh-voltage aluminum electrolytic capacitor and preparation method and application thereof | 上海交通大学 | 2021-06-08 | — | — | CN | claimed |
| CN-112028741-A | Electrolyte for ultrahigh-voltage aluminum electrolytic capacitor and preparation method and application thereof | 上海交通大学 | 2020-12-04 | — | — | CN | claimed |
| EP-2203434-B1 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI HOLDINGS CO LTD (KR) | 2012-08-29 | — | — | EP | claimed |
| US-8242288-B2 | Method of preparing (6R)-3-hexyl-4-hydroxy-6-undecyl-5, 6-dihydropyran-2-one, and intermediate used in the method | HANMI HOLDINGS CO., LTD. (KR) | 2012-08-14 | — | — | US | claimed |
| US-20100274029-A1 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5, 6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI PHARM. CO., LTD. (KR) | 2010-10-28 | — | — | US | claimed |
| CN-101842363-A | Process for preparing (6R) -3-hexyl-4-hydroxy-6-undecyl-5, 6-dihydropyran-2-one and intermediates used in the process | HANMI PHARM IND CO LTD | 2010-09-22 | — | — | CN | claimed |
| EP-2203434-A2 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | Hanmi Pharm. Co., Ltd. (KR) | 2010-07-07 | — | — | EP | claimed |
| WO-2009057938-A2 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI PHARM. CO., LTD. (KR) | 2009-05-07 | — | — | WO | claimed |
| CN-112028741-B | Electrolyte for ultrahigh-voltage aluminum electrolytic capacitor and preparation method and application thereof | 上海交通大学 | 2021-06-08 | — | — | CN | disclosed |
| CN-112028741-A | Electrolyte for ultrahigh-voltage aluminum electrolytic capacitor and preparation method and application thereof | 上海交通大学 | 2020-12-04 | — | — | CN | disclosed |
| EP-2203434-B1 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI HOLDINGS CO LTD (KR) | 2012-08-29 | — | — | EP | disclosed |
| US-8242288-B2 | Method of preparing (6R)-3-hexyl-4-hydroxy-6-undecyl-5, 6-dihydropyran-2-one, and intermediate used in the method | HANMI HOLDINGS CO., LTD. (KR) | 2012-08-14 | — | — | US | disclosed |
| US-20100274029-A1 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5, 6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI PHARM. CO., LTD. (KR) | 2010-10-28 | — | — | US | disclosed |
| EP-2203434-A2 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | Hanmi Pharm. Co., Ltd. (KR) | 2010-07-07 | — | — | EP | disclosed |
| WO-2009057938-A2 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI PHARM. CO., LTD. (KR) | 2009-05-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100274029-A1 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5, 6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | DHCR7, DHPS, CYP8B1 | ZDHHC7 387/4885LCK 2855/4885PPARD 1452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.